1315571-55-1

Basic information

• Product Name: 8-[((2S)-2-methyl-4-{[4-(trifluoromethyl)phenyl]sulfonyl}-1-piperazinyl)carbonyl]isoquinoline hydrochloride
• Synonyms: 8-[((2S)-2-methyl-4-{[4-(trifluoromethyl)phenyl]sulfonyl}-1-piperazinyl)carbonyl]isoquinoline hydrochloride
• CAS NO: 1315571-55-1
• Molecular Weight: 499.941
• Mol File: 1315571-55-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 8-[((2S)-2-methyl-4-{[4-(trifluoromethyl)phenyl]sulfonyl}-1-piperazinyl)carbonyl]isoquinoline hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 8-[((2S)-2-methyl-4-{[4-(trifluoromethyl)phenyl]sulfonyl}-1-piperazinyl)carbonyl]isoquinoline hydrochloride(1315571-55-1)
• EPA Substance Registry System: 8-[((2S)-2-methyl-4-{[4-(trifluoromethyl)phenyl]sulfonyl}-1-piperazinyl)carbonyl]isoquinoline hydrochloride(1315571-55-1)

Safety Data

• Hazardous Substances Data: 1315571-55-1(Hazardous Substances Data)

Upstream product

• 61563-43-7 isoquinoline-8-carboxylic acid 
• 1204535-11-4 (3S)-3-methyl-1-{[4-(trifluoromethyl)phenyl]sulfonyl}piperazine 
• 74879-18-8 (S)-2-methylpiperazine 

Relevant articles and documents

PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS

The present invention relates to novel piperazine compounds; to pharmaceutical compositions containing the compounds; and to the use of the compounds in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial and to treat diseases for which blocking the Cav2.2 and Cav3.2 calcium channels is beneficial, e.g. to treat pain.